Everolimus-eluting bioresorbable scaffolds for treatment of coronary artery disease in patients with diabetes mellitus: the midterm follow-up of the prospective ABSORB DM Benelux study
Crossref DOI link:
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hommels, T. M.
Hermanides, R. S.
IJsselmuiden, A. J. J.
Jessurun, G. A. J.
De Luca, G.
Funding for this research was provided by:
Maatschap Cardiologie Isala Hartcentrum, Isala Klinieken, Zwolle
Text and Data Mining valid from 2019-03-09
3 January 2019
18 February 2019
9 March 2019